| Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the computation of the basic and diluted net income per share attributable to common stockholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | (in thousands, except share and per share data) | | 2026 | | 2025 | | 2026 | | 2025 | Basic net income per share: | | | | | | | | | | Numerator: | | | | | | | | | | Net income, basic | | $ | 13,149 | | | $ | 26,751 | | | $ | 15,774 | | | $ | 27,521 | | | Denominator: | | | | | | | | | | Weighted-average common shares outstanding, basic | | 100,094,307 | | 122,854,629 | | 105,813,505 | | 124,229,932 | Net income per share: | | | | | | | | | Net income per share attributable to common stockholders, basic | | $ | 0.13 | | | $ | 0.22 | | | $ | 0.15 | | | $ | 0.22 | | | | | | | | | | | Diluted net income per share: | | | | | | | | | | Numerator: | | | | | | | | | Net income | | $ | 13,149 | | | $ | 26,751 | | | $ | 15,774 | | | $ | 27,521 | | | Fair value adjustment related to contingent consideration | | (200) | | | (23,400) | | | — | | | (21,600) | | Net income, diluted | | $ | 12,949 | | | $ | 3,351 | | | $ | 15,774 | | | $ | 5,921 | | | Denominator: | | | | | | | | | | Number of shares used in basic calculation | | 100,094,307 | | 122,854,629 | | 105,813,505 | | 124,229,932 | | Dilutive effect of employee stock-based awards | | 1,471,453 | | | 5,380,873 | | | 1,351,719 | | | 4,810,421 | | | Dilutive effect of incentive pool | | — | | | 1,129,194 | | | — | | | 1,254,875 | | | Dilutive effect of earnout arrangement | | 1,544,566 | | | 1,436,112 | | | — | | | 718,056 | | | Weighted-average common shares outstanding, diluted | | 103,110,326 | | 130,800,808 | | 107,165,224 | | 131,013,284 | Net income per share attributable to common stockholders, diluted | | $ | 0.13 | | | $ | 0.03 | | | $ | 0.15 | | | $ | 0.05 | |
|
| Schedule of Antidilutive Securities |
Anti-dilutive common equivalent shares that have been excluded from diluted net income per share were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | | 2026 | | 2025 | | 2026 | | 2025 | | Options to purchase common stock | | 500,239 | | | 181,750 | | | 511,102 | | | 507,946 | | | Restricted stock and restricted stock units | | 4,260,230 | | | 3,400,013 | | | 4,749,575 | | | 2,818,227 | | | Shares estimated to be purchased under ESPP | | 199,208 | | | — | | | 99,604 | | | — | | | Performance-based restricted stock units | | 6,708,478 | | | 2,995,000 | | | 7,697,000 | | | 2,862,500 | | | Contingent shares - earnout arrangement | | — | | | — | | | 1,441,158 | | | — | | | Total anti-dilutive common equivalent shares | | 11,668,155 | | | 6,576,763 | | | 14,498,439 | | | 6,188,673 | |
|